治疗方案-话题@MedSci

#治疗方案#

313篇内容 | 3238人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1905140, encodeId=ec36190514059, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Cell Res ：复旦大学发布三阴性乳腺癌精准治疗方案，让患者从山穷水尽到柳暗花明, objectType=article, longId=198326, objectId=2e6f1983269e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e6f1983269e, replyNumber=0, likeNumber=70, createdTime=2021-04-03, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e6f1983269e, moduleTitle=Cell Res ：复旦大学发布三阴性乳腺癌精准治疗方案，让患者从山穷水尽到柳暗花明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e6f1983269e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905141, encodeId=077719051411c, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Cell Res：全球首发！复旦大学发布三阴性乳腺癌精准治疗方案，让患者从山穷水尽到柳暗花明, objectType=article, longId=198384, objectId=332719838487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=332719838487, replyNumber=0, likeNumber=65, createdTime=2021-06-30, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=332719838487, moduleTitle=Cell Res：全球首发！复旦大学发布三阴性乳腺癌精准治疗方案，让患者从山穷水尽到柳暗花明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=332719838487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905125, encodeId=c3271905125a9, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=新冠肺炎血浆治疗方案增加内容：距首发症状时间不少于3周, objectType=article, longId=189485, objectId=45eb18948594, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45eb18948594, replyNumber=0, likeNumber=105, createdTime=2020-05-10, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45eb18948594, moduleTitle=新冠肺炎血浆治疗方案增加内容：距首发症状时间不少于3周, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45eb18948594)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905139, encodeId=61d71905139b4, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Cancer Immunol Immunother：卵巢癌免疫治疗方案的新研究探索, objectType=article, longId=197256, objectId=d6f519e256c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6f519e256c6, replyNumber=0, likeNumber=53, createdTime=2021-02-07, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6f519e256c6, moduleTitle=Cancer Immunol Immunother：卵巢癌免疫治疗方案的新研究探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6f519e256c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905113, encodeId=29c519051130e, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=85岁老人颅内巨大血肿危及生命！这个保守治疗方案帮他度过危险期, objectType=article, longId=182435, objectId=c9e5182435da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9e5182435da, replyNumber=0, likeNumber=76, createdTime=2020-01-25, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9e5182435da, moduleTitle=85岁老人颅内巨大血肿危及生命！这个保守治疗方案帮他度过危险期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9e5182435da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905130, encodeId=02d01905130b4, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Chest：肺移植受者非结核分枝杆菌围手术期和术后治疗方案的结局, objectType=article, longId=191575, objectId=793a1915e548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=793a1915e548, replyNumber=0, likeNumber=78, createdTime=2020-06-06, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=793a1915e548, moduleTitle=Chest：肺移植受者非结核分枝杆菌围手术期和术后治疗方案的结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=793a1915e548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905132, encodeId=ba58190513291, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=EClinicalMedicine：含有贝达奎林和/或德拉米尼的无注射剂治疗方案对青少年有效且耐受性良好, objectType=article, longId=191906, objectId=8c981919067e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c981919067e, replyNumber=0, likeNumber=93, createdTime=2020-04-11, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c981919067e, moduleTitle=EClinicalMedicine：含有贝达奎林和/或德拉米尼的无注射剂治疗方案对青少年有效且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c981919067e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905112, encodeId=68d8190511219, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Sci Rep：新的胰腺癌联合治疗方案可逆转肿瘤微环境！, objectType=article, longId=180988, objectId=170a18098829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=170a18098829, replyNumber=0, likeNumber=62, createdTime=2019-12-29, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=170a18098829, moduleTitle=Sci Rep：新的胰腺癌联合治疗方案可逆转肿瘤微环境！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=170a18098829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905118, encodeId=61ba19051185a, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet Haematol：5种一线晚期霍奇金淋巴瘤治疗方案成本效益评估, objectType=article, longId=186274, objectId=72631862e452, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72631862e452, replyNumber=0, likeNumber=65, createdTime=2020-08-29, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72631862e452, moduleTitle=Lancet Haematol：5种一线晚期霍奇金淋巴瘤治疗方案成本效益评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72631862e452)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905108, encodeId=6b1c19051084d, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=院内治疗却要在院外买药医生未制定合理治疗方案涉违规丨医法汇, objectType=article, longId=179394, objectId=5e911e9394f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e911e9394f2, replyNumber=0, likeNumber=61, createdTime=2020-08-16, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e911e9394f2, moduleTitle=院内治疗却要在院外买药医生未制定合理治疗方案涉违规丨医法汇, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e911e9394f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905133, encodeId=2ab019051330b, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=BMC Infect Dis：在中国采用含贝达喹啉治疗方案对耐药性结核病负担的长期影响, objectType=article, longId=191919, objectId=42e3191919a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42e3191919a1, replyNumber=0, likeNumber=74, createdTime=2020-08-30, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42e3191919a1, moduleTitle=BMC Infect Dis：在中国采用含贝达喹啉治疗方案对耐药性结核病负担的长期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42e3191919a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905136, encodeId=b4791905136f4, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Open Rheumatol J：研究发现应将减肥纳入肥胖OA患者的治疗方案, objectType=article, longId=193983, objectId=fad81939838a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fad81939838a, replyNumber=0, likeNumber=79, createdTime=2021-03-26, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fad81939838a, moduleTitle=Open Rheumatol J：研究发现应将减肥纳入肥胖OA患者的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fad81939838a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905129, encodeId=658c1905129fa, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=耐多药结核病治疗方案知多少？, objectType=article, longId=190636, objectId=5964190636b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5964190636b5, replyNumber=0, likeNumber=84, createdTime=2021-02-01, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5964190636b5, moduleTitle=耐多药结核病治疗方案知多少？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5964190636b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905120, encodeId=1c071905120b9, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=J Hepatology：基于干扰素的丙型肝炎治疗方案持续的病毒学应答与降低肝外表现的风险有关, objectType=article, longId=186949, objectId=a52718694904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a52718694904, replyNumber=0, likeNumber=74, createdTime=2020-11-21, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a52718694904, moduleTitle=J Hepatology：基于干扰素的丙型肝炎治疗方案持续的病毒学应答与降低肝外表现的风险有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a52718694904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905106, encodeId=0dc61905106c2, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=GUT：阿达木单抗强化治疗方案可提高CD患者治疗成本效益, objectType=article, longId=175092, objectId=268a1e5092e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=268a1e5092e3, replyNumber=0, likeNumber=74, createdTime=2020-02-24, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=268a1e5092e3, moduleTitle=GUT：阿达木单抗强化治疗方案可提高CD患者治疗成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=268a1e5092e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905101, encodeId=668c190510152, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=胡成平教授：EGFR突变阳性晚期NSCLC一线治疗方案选择, objectType=article, longId=168762, objectId=f104168e62dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f104168e62dd, replyNumber=0, likeNumber=67, createdTime=2019-12-18, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f104168e62dd, moduleTitle=胡成平教授：EGFR突变阳性晚期NSCLC一线治疗方案选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f104168e62dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905093, encodeId=25e9190509346, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Ⅱ/Ⅲ期胃癌患者D2切除术后更佳辅助治疗方案探索, objectType=article, longId=167331, objectId=a9b316e33144, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9b316e33144, replyNumber=0, likeNumber=60, createdTime=2019-08-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9b316e33144, moduleTitle=Ⅱ/Ⅲ期胃癌患者D2切除术后更佳辅助治疗方案探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9b316e33144)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905110, encodeId=64d01905110e7, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=BMJ：广医附一院何建行教授团队发文：EGFR突变晚期非小细胞肺癌更佳一线治疗方案, objectType=article, longId=180844, objectId=fd6d18084418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd6d18084418, replyNumber=0, likeNumber=80, createdTime=2020-03-01, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd6d18084418, moduleTitle=BMJ：广医附一院何建行教授团队发文：EGFR突变晚期非小细胞肺癌更佳一线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd6d18084418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905119, encodeId=51411905119cb, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=罗氏和Illumina宣布开展为期15年的癌症基因组学测序合作，为患者匹配更佳治疗方案, objectType=article, longId=186395, objectId=54d718639597, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54d718639597, replyNumber=0, likeNumber=71, createdTime=2020-07-31, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54d718639597, moduleTitle=罗氏和Illumina宣布开展为期15年的癌症基因组学测序合作，为患者匹配更佳治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54d718639597)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905105, encodeId=33b81905105dd, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=苏格兰医药联盟积极推荐Darzalex作为多发性骨髓瘤的二线治疗方案, objectType=article, longId=175081, objectId=1ce51e50810d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ce51e50810d, replyNumber=0, likeNumber=64, createdTime=2019-08-16, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ce51e50810d, moduleTitle=苏格兰医药联盟积极推荐Darzalex作为多发性骨髓瘤的二线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ce51e50810d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗方案

2020-05-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Cell Res ：复旦大学发布三阴性乳腺癌精准治疗方案，让患者从山穷水尽到柳暗花明

2021-04-03

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Cell Res：全球首发！复旦大学发布三阴性乳腺癌精准治疗方案，让患者从山穷水尽到柳暗花明

2021-06-30

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

新冠肺炎血浆治疗方案增加内容：距首发症状时间不少于3周

2020-05-10

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Cancer Immunol Immunother：卵巢癌免疫治疗方案的新研究探索

2021-02-07

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

85岁老人颅内巨大血肿危及生命！这个保守治疗方案帮他度过危险期

2020-01-25

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Chest：肺移植受者非结核分枝杆菌围手术期和术后治疗方案的结局

2020-06-06

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

EClinicalMedicine：含有贝达奎林和/或德拉米尼的无注射剂治疗方案对青少年有效且耐受性良好

2020-04-11

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Sci Rep：新的胰腺癌联合治疗方案可逆转肿瘤微环境！

2019-12-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet Haematol：5种一线晚期霍奇金淋巴瘤治疗方案成本效益评估

2020-08-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

院内治疗却要在院外买药医生未制定合理治疗方案涉违规丨医法汇

2020-08-16

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

BMC Infect Dis：在中国采用含贝达喹啉治疗方案对耐药性结核病负担的长期影响

2020-08-30

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Open Rheumatol J：研究发现应将减肥纳入肥胖OA患者的治疗方案

2021-03-26

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

耐多药结核病治疗方案知多少？

2021-02-01

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

J Hepatology：基于干扰素的丙型肝炎治疗方案持续的病毒学应答与降低肝外表现的风险有关

2020-11-21

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

GUT：阿达木单抗强化治疗方案可提高CD患者治疗成本效益

2020-02-24

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

胡成平教授：EGFR突变阳性晚期NSCLC一线治疗方案选择

2019-12-18

hb2008ye (审核中...)

前往app查看评论内容

#治疗方案#

Ⅱ/Ⅲ期胃癌患者D2切除术后更佳辅助治疗方案探索

2019-08-26

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

BMJ：广医附一院何建行教授团队发文：EGFR突变晚期非小细胞肺癌更佳一线治疗方案

2020-03-01

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

罗氏和Illumina宣布开展为期15年的癌症基因组学测序合作，为患者匹配更佳治疗方案

2020-07-31

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

苏格兰医药联盟积极推荐Darzalex作为多发性骨髓瘤的二线治疗方案

2019-08-16

科室
- - 订阅+
  - 更多科室
工具
服务